Investigation of the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care

NCT ID: NCT01957384

Last Updated: 2014-03-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the functionality and safety of the test products and also assess the products' ability to collect stool without interfering with the stoma. The degree of leakage using the product will also be measured

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy - Stoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment 1; First Coloplast Test product 1

The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of treatment to periods.

Subjects first testing Coloplast Test product 1 are randomised to secondly test either:

1. Coloplast Test product 2 and thereafter Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)
2. Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)and thereafter Coloplast Test product 2

Group Type EXPERIMENTAL

Coloplast Test product 1

Intervention Type DEVICE

Coloplast Test product 1 is a new ostomy appliance developed by Coloplast.

Coloplast Test product 2

Intervention Type DEVICE

Coloplast Test product 2 is a new ostmoy appliance developed by Coloplast A/S

Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)

Intervention Type DEVICE

Standard Care was the subject usual ostomy appliance and had to be one of the following:

* Coloplast: SenSura, 1-piece open bag without inspection window, size midi and maxi, custom-cut,
* Dansac: Nova 1 \& Nova Life, 1-piece open bag, size midi and maxi, custom-cut baseplate
* Hollister: Moderma Flex, 1-piece open, size midi and maxi, custom-cut baseplate
* ConvaTec: Esteem, 1-piece open bag, size midi and maxi, custom-cut baseplate
* B. Braun: Flexima Active \& Softima, 1-piece open bag, size midi and maxi, custom-cut baseplate

Treatment 2; First Coloplast Test product 2.

The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of treatment to periods.

Subjects first testing Coloplast Test product 2 are randomised to secondly test either:

1. Coloplast Test product 1 and thereafter Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)
2. Standard Care Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)and thereafter Coloplast Test product 1

Group Type EXPERIMENTAL

Coloplast Test product 1

Intervention Type DEVICE

Coloplast Test product 1 is a new ostomy appliance developed by Coloplast.

Coloplast Test product 2

Intervention Type DEVICE

Coloplast Test product 2 is a new ostmoy appliance developed by Coloplast A/S

Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)

Intervention Type DEVICE

Standard Care was the subject usual ostomy appliance and had to be one of the following:

* Coloplast: SenSura, 1-piece open bag without inspection window, size midi and maxi, custom-cut,
* Dansac: Nova 1 \& Nova Life, 1-piece open bag, size midi and maxi, custom-cut baseplate
* Hollister: Moderma Flex, 1-piece open, size midi and maxi, custom-cut baseplate
* ConvaTec: Esteem, 1-piece open bag, size midi and maxi, custom-cut baseplate
* B. Braun: Flexima Active \& Softima, 1-piece open bag, size midi and maxi, custom-cut baseplate

Treatment 3,First Standard care (see below)

The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of treatment to periods.

Subjects first testing Standard Care Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active) are randomised to secondly test either:

1. Coloplast Test product 1 and thereafter Coloplast Test product 2
2. Coloplast Test product 2 and thereafter Coloplast Test product 1

Group Type EXPERIMENTAL

Coloplast Test product 1

Intervention Type DEVICE

Coloplast Test product 1 is a new ostomy appliance developed by Coloplast.

Coloplast Test product 2

Intervention Type DEVICE

Coloplast Test product 2 is a new ostmoy appliance developed by Coloplast A/S

Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)

Intervention Type DEVICE

Standard Care was the subject usual ostomy appliance and had to be one of the following:

* Coloplast: SenSura, 1-piece open bag without inspection window, size midi and maxi, custom-cut,
* Dansac: Nova 1 \& Nova Life, 1-piece open bag, size midi and maxi, custom-cut baseplate
* Hollister: Moderma Flex, 1-piece open, size midi and maxi, custom-cut baseplate
* ConvaTec: Esteem, 1-piece open bag, size midi and maxi, custom-cut baseplate
* B. Braun: Flexima Active \& Softima, 1-piece open bag, size midi and maxi, custom-cut baseplate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coloplast Test product 1

Coloplast Test product 1 is a new ostomy appliance developed by Coloplast.

Intervention Type DEVICE

Coloplast Test product 2

Coloplast Test product 2 is a new ostmoy appliance developed by Coloplast A/S

Intervention Type DEVICE

Standard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)

Standard Care was the subject usual ostomy appliance and had to be one of the following:

* Coloplast: SenSura, 1-piece open bag without inspection window, size midi and maxi, custom-cut,
* Dansac: Nova 1 \& Nova Life, 1-piece open bag, size midi and maxi, custom-cut baseplate
* Hollister: Moderma Flex, 1-piece open, size midi and maxi, custom-cut baseplate
* ConvaTec: Esteem, 1-piece open bag, size midi and maxi, custom-cut baseplate
* B. Braun: Flexima Active \& Softima, 1-piece open bag, size midi and maxi, custom-cut baseplate

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have given written informed consent
* Be at least 18 years of age and have full legal capacity
* Be able to handle the bags themselves or with help from caregiver
* Have an ileostomy with a diameter between 15 and 45 mm
* Have had their ostomy for at least three months
* Currently use a 1-piece flat standard care product with open bag
* Negative result of a pregnancy test for women of childbearing age
* Custom-cut product user
* Be suitable for participation in the investigation

Exclusion Criteria

* Use irrigation during the study (flush the stoma with water)
* Currently receiving or have within the past 2 months received radio- and/or chemotherapy
* Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area
* Are pregnant or breastfeeding
* Participating in other interventional clinical investigations or have previously participated in this investigation
* Max three days wear time
* Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Birte Petersen

Role: PRINCIPAL_INVESTIGATOR

Coloplast A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coloplast A/S

Humlebæk, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP221

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimal Bowel Cleansing Trial
NCT01624454 COMPLETED NA